Evidence map›Paper›PMID 35261290›Full record

Trial reportJournal of the American Heart Association2022

Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.

Carlo Briguori, Roy O Mathew, Zhen Huang, Kreton Mavromatis, LaTonya J Hickson, Wei Ling Lau, Anoop Mathew, Sandeep Mahajan, David C Wheeler, Kathleen J Claes and 10 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Coronary Artery Disease in CKD-G5D Patients: An Update.Reviews in cardiovascular medicine · 2023
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 8 countries.

Carlo BriguoriMediterranea Cardiocentro Naples Italy.ORCID 0000-0002-2105-8186
Roy O MathewLoma Linda VA Health Care System Loma Linda CA.ORCID 0000-0002-5582-3165
Zhen HuangDuke Clinical Research Institute Duke University Medical Center Durham NC.
Kreton MavromatisAtlanta VA Healthcare System and Emory University School of Medicine Atlanta GA.
LaTonya J HicksonMayo Clinic Jacksonville FL.ORCID 0000-0002-7485-336X
Wei Ling LauDivision of Nephrology Department of Medicine University of California-Irvine Irvine CA.
Anoop MathewUniversity of Alberta Hospital Edmonton Alberta Canada.ORCID 0000-0002-0302-1419
Sandeep MahajanAll India Institute of Medical Sciences Delhi India.
David C WheelerUniversity College London London United Kingdom.ORCID 0000-0003-0745-3478
Kathleen J ClaesDepartment of Nephrology University Hospitals Leuven Leuven Belgium.
Gang ChenPeking Union Medical College Hospital Beijing China.
Fernando E B NolascoCentro Hospitalar Lisboa Central Lisbon Portugal.
Gregg W StoneIcahn School of Medicine at Mount Sinai New York NY.ORCID 0000-0002-3416-8210
Jerome L FlegNational Heart, Lung, and Blood Institute Bethesda MD.
Mandeep S SidhuAlbany Medical College Albany NY.
Frank W RockholdDuke Clinical Research Institute Duke University Medical Center Durham NC.ORCID 0000-0003-3732-4765
Glenn M ChertowStanford University School of Medicine Stanford CA.
Judith S HochmanNYU Grossman School of Medicine New York NY.ORCID 0000-0002-5889-5981
David J MaronStanford University School of Medicine Stanford CA.
Sripal BangaloreNYU Grossman School of Medicine New York NY.ORCID 0000-0001-9485-0652
Clinical Research Institute · USNew York University · USStanford University · USAlbany Medical Center Hospital · USAlberta Hospital Edmonton · CAAll India Institute of Medical Sciences · INCardiovascular Research Foundation · USChinese Academy of Medical Sciences & Peking Union Medical College · CNClinica Mediterranea · ITEmory University · USJacksonville College · USKU Leuven · BENational Heart Lung and Blood Institute · USUnidade Local de Saúde de São José · PTUniversity College London · GBUniversity of California, Irvine · USVA Loma Linda Healthcare System · US

Funding

The Ischemia Trial - CCCU01HL105907 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOCHMAN, JUDITH S · 2011 to 2019
$100.1M
The ISCHEMIA-CKD Trial-CCC-Lead ApplicationU01HL117905 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BANGALORE, SRIPAL · 2013 to 2019
$9.8M
ISCHEMIA-CKD SDCCU01HL117904 · NHLBI · DUKE UNIVERSITY · PI O'BRIEN, SEAN M · 2013 to 2019
$1.5M
NHLBI NIH HHS U01 HL105907NHLBI NIH HHS U01 HL117904NHLBI NIH HHS U01 HL117905
6 · The paper itself

Abstract

Background In participants with concomitant chronic coronary disease and advanced chronic kidney disease (CKD), the effect of treatment strategies on the timing of dialysis initiation is not well characterized. Methods and Results In ISCHEMIA-CKD (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Chronic Kidney Disease), 777 participants with advanced CKD and moderate or severe ischemia were randomized to either an initial invasive or conservative management strategy. Herein, we compare the proportion of randomized participants with non-dialysis-requiring CKD at baseline (n=362) who initiated dialysis and compare the time to dialysis initiation between invasive versus conservative management arms. Using multivariable Cox regression analysis, we also sought to identify the effect of invasive versus conservative chronic coronary disease management strategies on dialysis initiation. At a median follow-up of 23 months (25th-75th interquartile range, 14-32 months), dialysis was initiated in 18.9% of participants (36/190) in the invasive strategy and 16.9% of participants (29/172) in the conservative strategy

Indexed as

Coronary DiseaseHeart DiseasesRenal Insufficiency, ChronicGlomerular Filtration RateHumansIschemiaRenal Dialysischronic coronary diseasechronic kidney diseasedialysisguideline‐directed medical therapy

Identifiers

PMID35261290
PMCPMC9075321
OpenAlexW4220810046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.